CLINICAL_TRIALS
trial_result
· 2018-12-07
Clinical Trial Update: Clinical Study to Evaluate the Efficacy and Safety of Desoximetasone (DSXS) With Atopic Dermatitis [Phase 3]
Summary
A Phase 3 clinical trial evaluating desoximetasone (DSXS) for efficacy and safety in atopic dermatitis has completed, with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-07